Back to Journals » Pharmacogenomics and Personalized Medicine

Pharmacogenomics and Personalized Medicine


ISSN: 1178-7066

Editor-in-Chief: Dr Martin H Bluth

An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

Latest articles:

- 5 records -

Association of CYP7A1 and CYP2E1 Polymorphisms with Type 2 Diabetes in the Chinese Han Populations

Zhang L, Tang J, Wang Y, Wang X, Wang F

Pharmacogenomics and Personalized Medicine 2022, 15:843-855

Published Date: 21 September 2022

Contribution of ZBTB20 Polymorphisms to Esophageal Cancer Risk Among the Chinese Han Population

Yu S, Yuan G, Hu F, Li Y, Chen Z, Zhang R, Li P, Chen Z, Song J

Pharmacogenomics and Personalized Medicine 2022, 15:827-842

Published Date: 20 September 2022

IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia

Abdalhabib EK, Alzahrani B, Saboor M, Hamza A, Elfaki EM, Alanazi F, Alenazy FO, Algarni A, Khider Ibrahim I, Mohamed HA, Hussein Alfeel A, Ali Alshaikh N

Pharmacogenomics and Personalized Medicine 2022, 15:809-815

Published Date: 12 September 2022


Read more articles